Fusion Antibodies PLC - ESG Rating & Company Profile powered by AI
This assessment of Fusion Antibodies PLC was assembled by All Street Sevva using proprietary NLP. This Disclosure rating covers 17 United Nations Sustainable Development Goals including: 'Zero Hunger', 'Reduced Inequalities' and 'Peace, Justice & Strong Institutions'. Jump to the bottom of this webpage for potential risks for Fusion Antibodies PLC based on industry, location and marketcap.
Fusion Antibodies PLC in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 3.1; made up of an environmental score of 4.0, social score of 2.7 and governance score of 2.7.
3.1
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| ... | ... | ... | |
| 1299 | Active Fine Chemicals Ltd | 3.2 | Medium |
| 1299 | Yuhan Corp | 3.2 | Medium |
| 1309 | Fusion Antibodies PLC | 3.1 | Medium |
| 1309 | Champions Oncology Inc | 3.1 | Medium |
| 1309 | IBEX Technologies Inc | 3.1 | Medium |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Fusion Antibodies PLC have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Fusion Antibodies PLC disclose current and historical energy intensity?
Sign up for free to unlockDoes Fusion Antibodies PLC report the average age of the workforce?
Sign up for free to unlockDoes Fusion Antibodies PLC reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Fusion Antibodies PLC disclose its ethnicity pay gap?
Sign up for free to unlockDoes Fusion Antibodies PLC disclose cybersecurity risks?
Sign up for free to unlockDoes Fusion Antibodies PLC offer flexible work?
Sign up for free to unlockDoes Fusion Antibodies PLC have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Fusion Antibodies PLC disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Fusion Antibodies PLC conduct supply chain audits?
Sign up for free to unlockDoes Fusion Antibodies PLC disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Fusion Antibodies PLC conduct 360 degree staff reviews?
Sign up for free to unlockDoes Fusion Antibodies PLC disclose the individual responsible for D&I?
Sign up for free to unlockDoes Fusion Antibodies PLC disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Fusion Antibodies PLC disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Fusion Antibodies PLC disclose water use targets?
Sign up for free to unlockDoes Fusion Antibodies PLC have careers partnerships with academic institutions?
Sign up for free to unlockDid Fusion Antibodies PLC have a product recall in the last two years?
Sign up for free to unlockDoes Fusion Antibodies PLC disclose incidents of discrimination?
Sign up for free to unlockDoes Fusion Antibodies PLC allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Fusion Antibodies PLC issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Fusion Antibodies PLC disclose parental leave metrics?
Sign up for free to unlockDoes Fusion Antibodies PLC disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Fusion Antibodies PLC disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Fusion Antibodies PLC disclose the pay ratio of women to men?
Sign up for free to unlockDoes Fusion Antibodies PLC support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Fusion Antibodies PLC disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Fusion Antibodies PLC reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Fusion Antibodies PLC involved in embryonic stem cell research?
Sign up for free to unlockDoes Fusion Antibodies PLC disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Fusion Antibodies PLC disclose its waste policy?
Sign up for free to unlockDoes Fusion Antibodies PLC report according to TCFD requirements?
Sign up for free to unlockDoes Fusion Antibodies PLC disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Fusion Antibodies PLC disclose energy use targets?
Sign up for free to unlockDoes Fusion Antibodies PLC disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Fusion Antibodies PLC have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Fusion Antibodies PLC
These potential risks are based on the size, segment and geographies of the company.
Fusion Antibodies plc, a contract research organization, engages in the research, development, and manufacture of recombinant proteins and antibodies primarily for cancer and infectious diseases in the United Kingdom, the rest of Europe, North America, and internationally. The company offers monoclonal antibody discovery and development, antibody sequencing, antibody engineering, antibody humanization and rational affinity maturation platform, recombinant protein expression, and stable cell line development and cGMP scale up services. It serves pharmaceutical, biotech, and diagnostic companies. The company has a collaboration partnership with Celonic AG. Fusion Antibodies plc was incorporated in 2000 and is headquartered in Belfast, the United Kingdom.